Drug treatment in heart failure

British Medical Journal

Volumn 320, Issue 7243, 2000, Pages 1188-1192

  Lonn, Eva ^a   McKelvie, Robert ^a  

^a HAMILTON HEALTH SCIENCES   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; AMILORIDE; AMIODARONE; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUMETANIDE; CAPTOPRIL; CARVEDILOL; DIGITALIS; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ETACRYNIC ACID; FOSINOPRIL; FUROSEMIDE; HYDRALAZINE; HYDROCHLOROTHIAZIDE; ISOSORBIDE DINITRATE; LISINOPRIL; METOLAZONE; METOPROLOL; RAMIPRIL; SPIRONOLACTONE; TRIAMTERENE;

ANGIONEUROTIC EDEMA; ANOREXIA; BRADYCARDIA; COUGHING; ELECTROLYTE DISTURBANCE; FLUID RETENTION; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPERKALEMIA; HYPOTENSION; KIDNEY FAILURE; NAUSEA; PRIORITY JOURNAL; SHORT SURVEY; SYNCOPE; UREMIA; VOMITING;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; DIGITALIS; DIURETICS; HEART FAILURE, CONGESTIVE; HUMANS; PHYTOTHERAPY; PLANTS, MEDICINAL; PLANTS, TOXIC;

EID: 0034728798     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (26)

1. 1 Poole-Wilson PA. History, definition and classification of heart failure. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coates ALS, eds. Heart failure. Scientific principles and clinical practice. London: Churchill Livingstone, 1997:269-77.
2. 2 American Heart Association. 1998 Heart and stroke statistical update. Dallas, TX: AHA, 1997.
3. 3 Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J 1997;133:703-12.
4. 4 Sutton GC, Cowie MR. Epidemiology of heart failure in Europe. In: Poole-Wilson PA, Colucci WS, Massie BM, Chatterjee K, Coates ALS, eds. Heart failure. Scientific principles and clinical practice. London: Churchill Livingstone, 1997:617-33.
5. 5 The Task Forte of the Working Group on Heart Failure of the European Society of Cardiology The treatment of heart failure. Eur Heart J 1997;18:736-53.
6. 6 The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the cooperative north Scandinavian enalapril survival study (CONSENSUS). N Engl J Med 1986;314:1547-52.
7. 7 The Study of Left Ventricular Dysfunction (SOLVD) Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. N Engl J Med 1991;325:293-302.
8. 8 Garg R, Yusuf S for the Collaborative Group on angiotensin converting enzyme (ACE) Inhibitor Trials. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA 1995;273:1450-6.
9. 9 Pfeffer MA, Braunwald E, Moy LA, Basts L, Brown EJ, Cuddy TE, et al on behalf of the urvival and Ventricular Enlargement (SAVE) Investigators. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1992;327:669-77.
10. 10 The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-8.
11. 11 Kobei L,Torp-Pederson C, Carlsen JE, Bagger H, Eliasen P, Lyngborg K, et al for the Trandolapril Cardiac Evaluation (TRACE) Study Group. A clinical trial of the angiotensin-converting-enzyme trandolapril in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 1995;333:1670-6.
12. 12 Yusuf S, Lonn EM. Anti-ischemic effects of ACE inhibitors: review of current clinical evidence and ongoing clinical trials. Eur Heart J 1998;19(Suppl J):34-44J.
13. 13 The Study of Left Ventricular Dysfunction (SOLVD) Investigators. Effects of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 1992;327:575-6.
14. 14 Packer M, Pool-Wilson P, Armstrong P, Cleland J, Horowitz J, Massie B, et al. Comparative effects of low-dose versus high-dose lisinopril on survival and major ischemic events in chronic heart failure: the Assessment of treatment with lisinopril and survival study (ATLAS). Eur Heart J 1908;19(Suppl):142. (Abstract.)
15. 15 Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, et al for the Metprolol in Dilated Cardiomyopathy (MDC.) Trial Study Group. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet 1993;342:1441-6.
16. 16 CIBIS Investigators and Committees. A randomized trial of β-blockade in heart failure: the cardiac insufficiency bisoprolol study (CIBIS). Circulation 1994;90:1765-73.
17. 17 CIBIS Investigators and Committees. The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomized trial. Lancet 1999;353:9-13.
18. 18 Packer M, Bristow MR, Cohn JN, Colicci WS, Fowler MB, Gilbert EM, et al for the US Carvedilol Heart Failure Study Group. The effect of carvvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med 1996;34:1349-55.
19. 19 Australia and New Zealand Heart Failure Study Group. Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischemic heart disease. Lancet 1997;349:1349-55.
20. 20 Lechat P, Packer M, Chalon S, Cucherat M, Arab T, Boissel J-P. Clinical effects of β-adrenergic blockade in chronic heart failure. Circulation 1998;98:1184-91.
21. 21 DiBianco R, Shabetai R, Kostuk W, Moran J, Schlant RC, Wright R. A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989;20:677-83.
22. 22 Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK, et al on behalf of the Prospective Randomized Study of Ventricular Failure and the Efficacy of Digoxin (PROVED) Investigators. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED Trial. J Am Coll Cardiol 1993;22:955-62.
23. 23 Packer M, Gheorghiade M, Young JB, Constantini PJ, Adams KF, Cody RJ, et al for the randomized assessment of digoxin on inhibitors of the angiotensin-converting enzyme (RADIANCE) study. Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med 1993;329:1-7.
24. 24 The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336:525-33.
25. 25 SHEP Cooperative Research Group. Prevention of stroke by antihypertensive treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP). JAMA 1991;265:3255-64.
26. 26 Kjelshus J, Pederson T. Lowering cholesterol with simvastatin may prevent development of heart failure in patients with coronary artery disease. J Am Coll Cardiol 1995;25:282A.